Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on November 5, 2026

Nov. 5, 2026

Genius Group, FingerMotion and BlueFlare Sign Second Binding Agreement for Up to 100 MW Brooks Corridor HPC Campus Program in Alberta

Indeterminate GlobeNewswire

Nov. 5, 2026

Minty Launches Its 10x Cashback Sale, With Up to 10 Times Cashback on Participating Brands in the Minty App and Free AI Shopping Prompts to Save More

Indeterminate GlobeNewswire

Nov. 5, 2026

LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)

Indeterminate GlobeNewswire

Nov. 5, 2026

Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12

Indeterminate GlobeNewswire

Nov. 5, 2026

NETSOL Technologies to report fiscal first quarter 2027 results on November 12

Indeterminate GlobeNewswire

Nov. 5, 2026

Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Novastra Therapeutics Establishes Scientific Advisory Board and Appoints Senior Advisors and Head of Clinical Development

Indeterminate GlobeNewswire

Nov. 5, 2026

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 5, 2026

Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

AceUp Elevates Leadership Development Amid AI Transformation for NTT DATA Business Solutions with Ally 3.0

Indeterminate GlobeNewswire

Nov. 5, 2026

Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis

Indeterminate GlobeNewswire

Nov. 5, 2026

Nova Anchora Announces $23 Million Financing to Advance Topical Collagen VII Therapy for Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire

Nov. 5, 2026

Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets

Indeterminate GlobeNewswire

Nov. 5, 2026

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product

Indeterminate GlobeNewswire

Nov. 5, 2026

Immutep Announces Upcoming Poster Presentations at CTOS 2026 and ESMO Immuno-Oncology & Advanced Therapies Congress 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model

Indeterminate GlobeNewswire

Nov. 5, 2026

Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Nov. 5, 2026

Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire